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LETTERS TO THE EDITOREDEMA DOES MATTER
To the Editor:
My colleagues and I read with great
interest the recent article by Butler and
colleagues titled, ‘‘Dysfunction In-
duced by Ischemia Versus Edema:
Does Edema Matter?’’1 The authors
demonstrated significant myocyte
swelling after exposure to ischemia
and hypotonic solutions (0.75 T) and
reduced myocyte contractility after ex-
posure to the ischemic solution but not
the hypotonic solution. In an isolated
rat heart model, they demonstrated
a significant reduction in systolic func-
tion during exposure to hypotonic
solution. The authors conclude that
their data argue against edema as a ma-
jor contributor to reduced cardiac per-
formance.
Data from our laboratory using a dif-
ferent ischemic solution (metabolic in-
hibition) demonstrate that ischemia
does result in isolated myocyte swell-
ing and reduced contractility, similar
to the authors’ findings. However,
when we evaluated changes in isolated
myocytes exposed to isolated osmotic
challenges, we found a direct relation-
ship between volume change and
contractility. This relationship was
consistent after exposure to both hypo-
tonic and hypertonic solutions.2 Hy-
pertonic solutions were associated
with improved isolated myocyte con-
tractility. Hypotonic solutions (0.9 T
and 0.6 T) were associated with a re-
duction in myocyte contractility that
was clearly related to the amount of
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confirmed these findings in isolated
human myocytes (after exposure to os-
motic challenge as well as metabolic
inhibition) (unpublished). We have
thus proposed that during cardiac sur-
gery, myocyte edema secondary to os-
motic challenge (including exposure to
commonly used cardioplegic solu-
tions) does detrimentally affect con-
tractility in a manner that is separate
from, and additive to, the widely recog-
nized ‘‘ischemia-based’’ edema and
reduced contractility.3
Experimental differences between
the two articles exist in that the authors
used a shorter protocol (8 vs 20 min-
utes of exposure), different ischemic
and hypotonic solutions, and a differ-
ent species, all of which may make
direct comparisons of data difficult.
However, the relationship between
isolated myocyte swelling and con-
tractility has been consistently and
repeatedly demonstrated in our labora-
tory after exposure to hyperkalemic
cardioplegia, osmotic stress, and meta-
bolic inhibition in myocytes obtained
from two animal species and humans.
Jennifer S. Lawton, MD
Division of Cardiothoracic Surgery
Washington University School of
Medicine and Barnes Jewish Hospital
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We thank Dr Lawton for her interest
in our article1 and the Editor for theardiovascular Surgery c February 2010opportunity to respond. Our principal
focus is postoperative low cardiac
output syndrome (LCOS) in pediatric
patients. By studying myocardial
water content and function, we were
expecting to scientifically validate the
clinical dogma linking edema with
dysfunction. However, use of three
related models—isolated myocytes,
Langendorff hearts,1 and whole
animals on cardiopulmonary by-
pass2— failed to implicate edema as
a significant causal influence in LCOS.
We found that cells swelled in re-
sponse to hypotonic stress (7%)
more than they did in response to is-
chemia (2%). Cell function was not
changed during or after swelling alone
but severely affected by ischemia (re-
duced to 51% of baseline). When hy-
potonic stress followed the ischemic
insult, we showed additional edema
(from 2% to 6%) but no additional
contractile dysfunction. From these
findings, we assert that ischemia is
the most important influence on con-
tractile function.
We examined a single tonic change
(0.75 T)1 whereas the Lawton group
(Mizutani and associates3) used both
mild (0.9 T) and severe (0.6 T) hypo-
tonic exposure. Cell shortening was
identically reduced after recovery in
both the 0.9 T and 0.6 T groups
(30%) and was also reduced in the
1.0 T isotonic control (15%–20%).
Much of the impairment is simply tem-
poral decline, also seen in our study by
repeated measurement of isotonic con-
trols and a characteristic of the model
itself. In the Lawton study, statistical
significance could only be shown by
comparison of the 0.6 T and 0.9 T
groups with a 2.6 T hypertonic group.
No significant difference was shown in
cell function between 0.6 T, 0.9 T, and
isotonic buffers in agreement with our
own work.
In the Lawton group’s study, degree
of swelling correlated well with sever-
ity of tonic change, but cell shortening
was not affected to the same degree.
For cells exposed to 0.6 T buffer,
30% swelling was seen, whereas cells
Letters to the Editorexposed to 0.9 T showed a 7% in-
crease in volume. Shortening was re-
duced by approximately 30% after
recovery in both 0.6 T and 0.9 T
groups. Thus, despite a 23% differ-
ence in size between groups, there
was no difference in function.3 This ar-
gues against a direct relationship be-
tween edema and dysfunction.
In Dr Lawton’s study, function was
measured only in the recovery phase,
when cardiomyocytes had returned to
their normal size and not during the
time in which cells were swollen.
Yet, in the clinical context, edema
and dysfunction occur concurrently,
and this has largely been the basis for
a causal association to be drawn. Data
we present from Langendorff-based
analyses show only a limited associa-
tion exists. An increase in water con-
tent of 3.3% was associated with
a 9% reduction in developed pressure,
which in this model is a modest de-
cline. Developed pressure was stable
for up to 20 minutes of hypotonic expo-
sure and returned to baseline with iso-
tonic reperfusion.1 Our surgical
modeling suggests that swelling is tol-
erated for several hours without func-
tional effect. Thus, it is unlikely that
the duration of hypotonic exposure,
a further methodologic difference be-
tween our studies, was responsible for
the lack of edema-related dysfunction.
It must be acknowledged that exper-
imental separation of tonicity from is-
chemia, removing osmotic influences
of the interstitial and vascular com-
partments, is highly artificial. Future
use of human myocytes in this model
will also be subject to the same ca-
veats. It is likely that the dogma relat-
ing edema to dysfunction confuses
extracellular water accumulation, as
a result of capillary leak and renal ef-
fects of lower cardiac output, with in-
tracellular water accumulation,
which is well tolerated by the heart
and quickly resolves through trans-
membrane water exchange.4,5
The most credible interpretation of
data from both our groups is that the
swollen heart of ‘‘myocardial edema’’The Journalas observed by surgeons after long
neonatal cardiac surgery actually
represents the effects of myocardial
dysfunction with the ventricles work-
ing at a higher intracavitary volume
and reduced fractional shortening,
almost all of which can be attributed
to the effects of ischemia and reperfu-
sion. The water content of the myocar-
dium itself may be increased by a few
percentage points, and this contributes
to a decrease in cardiac performance
by a similar amount.
Tanya L. Butler, PhD
Jonathan R. Egan, MBBS, PhD
David Scott Winlaw, MD, FRACS
The Children’s Hospital at Westmead
Sydney, Australia
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STENT-GRAFT INFECTION IN
THE TREATMENT OF
AORTOBRONCHIAL
FISTULAS?
To the Editor:
A recent article by Hacker and col-
leagues1 describes a single case report
of aortobronchial fistula (ABF) in a pa-
tient who was successfully treated (27
years ago) for isthmic posttraumaticof Thoracic and Cardiovascular Surgepseudoaneurysm by placement of tho-
racic endoprosthesis. The authors con-
clude by saying that ‘‘endovascular
intervention and stent grafting are fea-
sible and should be the first option in
the treatment of ABFs.’’
We agree that ABF is a rare and fatal
disease and most frequently associated
with previous cardiac, vascular, or
thoracic surgery. Surgical treatment
is still characterized by high rates of
mortality and morbidity. Our article2
showed that it is not possible to identify
a half-accurate diagnostic instrument:
angiography, bronchoscopy, and trans-
esophageal echocardiography are asso-
ciated with a high rate of complications,
including fatal hemorrhage. Findings
suggestive of ABF on computed to-
mography scan include pseudoaneur-
ysm, aortic anatomy abnormalities,
lung parenchyma consolidation, and
compression of bronchial tree.
Conventional open surgical correc-
tion involves a thoracotomy and has
fairly high morbidity and mortality be-
cause of difficult operative dissection
associated with reoperative surgery;
in addition, patients may have severe
comorbidities and present in rather
poor health. Endovascular stent graft-
ing provides a safe and reliable method
to treat ABF.
One potential life-threatening compli-
cation is stent-graft infection; however,
in our experience, no signs of infections
were detected by postoperative scintig-
raphy with labeled leukocytes.
It is unclear why the infection rate
for endovascular repair is minimal,
but the stent graft remains in the center
of the aneurysm sac well away from
the actual fistula and source of contam-
ination. Perhaps because there is
minimal tissue trauma associated
with the deployment of the stent graft,
as opposed to open surgical repair, the
excluded aneurysmal or pseudo-aneu-
rysmal cavity is less likely to become
contaminated or infected.
Postoperative antibiotic treatment
differs completely among the various
authors, both with regard to the antibi-
otic (cephalosporin, vancomycin,ry c Volume 139, Number 2 511
